Market Place
Sourcing Support
All News #Library
Biotech
Aardvark Halts Obesity Trials, Putting Entire Pipeline On Pause
24 Mar 2026 //
FIERCE BIOTECH
Aardvark Therapeutics: Q4 FY 2025 Results & Update
23 Mar 2026 //
GLOBENEWSWIRE
Aardvark Pauses Ph. 3 Hunger Trial Over `Cardiac Observations`
02 Mar 2026 //
FIERCE BIOTECH
Aardvark Therapeutics Announces Inducement Grants
13 Feb 2026 //
GLOBENEWSWIRE
Aardvark Sets Up New US Subsidiary; Bryan Jones Named CEO
12 Feb 2026 //
GLOBENEWSWIRE
Aardvark Therapeutics Initiates HERO Ph 3 Trial In Australia
10 Dec 2025 //
GLOBENEWSWIRE
Aardvark Therapeutics To Present At Investor Conferences
25 Nov 2025 //
GLOBENEWSWIRE
Aardvark Therapeutics To Showcase Pipeline Programs
22 Oct 2025 //
GLOBENEWSWIRE
Ascentage Pharma’s US Shares Climb After $126 M IPO
25 Jan 2025 //
FIERCE BIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.